Oxford Handbook of Clinical Pharmacy

Complementing the guidelines in the British National Formulary, the third edition of the Oxford Handbook of Clinical Pharmacy remains the indispensable guide to clinical pharmacy, providing all the information needed for practising and student pharmacists. It presents handy practical guidance in a quick-reference, bullet-point format to give the reader the knowledge and confidence needed to provide a clinical pharmacy service.

Including key information on controlled drugs, adverse drug reactions, interactions, communication skills, and confidentiality, this extensively revised addition to the bestselling Oxford Handbook series is the fundamental pharmacy reference tool. It features chapters on adherence, anaphylaxis, clinical trials, herbal medicines, palliative care, patient management, pharmaceutical calculations, research, policy, and therapy related issues.

Thoroughly revised and updated, the Oxford Handbook of Clinical Pharmacy includes brand new topics, including content on health coaching, residency and on-call, HIV and TB and mental health.

Philip Wiffen, Editor in Chief European Journal of Hospital Pharmacy & Editor of Cochrane Pain; Palliative and Supportive Care Group, Pain Research Unit, Oxford University Hospitals NHS Trust, UK, Marc Mitchell, Divisional Pharmacist, Surgery and Oncology, Oxford University Hospitals NHS Trust, UK, Melanie Snelling, Lead Pharmacist, HIV and Infectious Diseases, Oxford University Hospitals NHS Trust, UK, Nicola Stoner, Cancer Consultant Pharmacist, Cancer Pharmacy Office, Oxford Cancer & Haematology Centre and Oxford Cancer Research Centre, Churchill Hospital, Oxford University Hospitals NHSTrust, UK

Philip Wiffen has been involved in clinical pharmacy since its inception in the 1970s. Having set up the Cochrane Pain, palliative and supportive care group in 1998, he is now actively involved in chronic pain research and systematic reviews. Phil is editor in chief of a major hospital pharmacy journal, and is driven by a strong desire to see hospital pharmacists undertaking research and publishing in peer reviewed journals.

Marc Mitchell started his career as one of the first resident pharmacists in the UK, and his career has involved working as clinical pharmacist across a variety of specialities including surgery, neurosciences, renal transplantation, medicine, cardiology, intensive care, haematology and oncology.
Marc is currently based at the Oxford University Hospitals Trust, and is still involved clinically as a non-medical prescriber in oncology, though main role as clinical pharmacy manager. He continues to be passionate about developing the skills and knowledge of the pharmacy workforce.

Mel Snelling is Lead HIV and Infectious Diseases Pharmacist for the Oxford University Hospitals NHS Foundation Trust a post she has held since 1993. A non-medical prescriber and with an interest in coaching for health she especially uses these skills in supporting adherence for patients with HIV. Prior to this role Mel spent three years as Assistant Region Drug Information Pharmacist for Oxford Region Health Authority, during which time she completed an MPhil thesis on Risk Factors for Adverse Drug Reactions. During 2000 and 2001, Mel worked at Bugando Medical Centre, a tertiary referral hospital in Tanzania, introducing a basic Clinical Pharmacy service to the hospital. She has continued her African connections by training on HIV treatment and care in Uganda and South Africa.

Nicola Stoner is Consultant Cancer Pharmacist at Oxford University Hospitals NHS Foundation Trust, and Visiting Professor at the School of Chemistry, Food and Pharmacy, University of Reading. Nicola is responsible for the clinical pharmacy service provision at the Oxford Cancer & Haematology Centre and the Oxford Cancer Research Centre, with the support of the cancer pharmacy team. Nicola is a non-medical prescriber and practices in the multidisciplinary colorectal clinic prescribing chemotherapy and supportive care. Nicola has specialised in cancer since 1990, and completed her PhD in anti-emetics in cancer chemotherapy in 1993. Her areas of expertise include cancer clinical trials, gene therapy, anti-emetics, cancer treatments and supportive care, electronic chemotherapy prescribing, pharmacist prescribing, patient adherence and pharmacy practice research.